These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 30580075)
61. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study. Spertini F; DellaCorte G; Kettner A; de Blay F; Jacobsen L; Jutel M; Worm M; Charlon V; Reymond C J Allergy Clin Immunol; 2016 Jul; 138(1):162-8. PubMed ID: 27373329 [TBL] [Abstract][Full Text] [Related]
62. Sublingual or subcutaneous immunotherapy for allergic rhinitis? Durham SR; Penagos M J Allergy Clin Immunol; 2016 Feb; 137(2):339-349.e10. PubMed ID: 26853126 [TBL] [Abstract][Full Text] [Related]
63. The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook. Pajno GB; Nadeau KC; Passalacqua G; Caminiti L; Hobson B; Jay DC; Arasi S; Chiera F; Salzano G Expert Rev Clin Immunol; 2015 Jan; 11(1):141-54. PubMed ID: 25454510 [TBL] [Abstract][Full Text] [Related]
64. Current and future directions in pediatric allergic rhinitis. Gentile D; Bartholow A; Valovirta E; Scadding G; Skoner D J Allergy Clin Immunol Pract; 2013; 1(3):214-26; quiz 227. PubMed ID: 24565478 [TBL] [Abstract][Full Text] [Related]
65. Pollen-induced allergic rhinitis in 1360 Italian children: comorbidities and determinants of severity. Dondi A; Tripodi S; Panetta V; Asero R; Businco AD; Bianchi A; Carlucci A; Ricci G; Bellini F; Maiello N; del Giudice MM; Frediani T; Sodano S; Dello Iacono I; Macrì F; Massaccesi V; Caffarelli C; Rinaldi L; Patria MF; Varin E; Peroni D; Chinellato I; Chini L; Moschese V; Lucarelli S; Bernardini R; Pingitore G; Pelosi U; Tosca M; Paravati F; La Grutta S; Meglio P; Calvani M; Plebani M; Matricardi PM; Pediatr Allergy Immunol; 2013 Dec; 24(8):742-51. PubMed ID: 24236692 [TBL] [Abstract][Full Text] [Related]
66. A 10-year experience of a novel and safe modified environmental rush immunotherapy protocol. Fajt ML; Rosenberg SL; Yecies E; Traister RS; Petrov AA Allergy Asthma Proc; 2017 Jul; 38(4):309-316. PubMed ID: 28668111 [TBL] [Abstract][Full Text] [Related]
67. Specific immunotherapy for allergic rhinitis in children. Wang C; Zhang L Curr Opin Otolaryngol Head Neck Surg; 2014 Dec; 22(6):487-94. PubMed ID: 25207858 [TBL] [Abstract][Full Text] [Related]
68. [The research progress of mechanism of allergen immunotherapy in allergic rhinitis]. Kong Y; Jiao W; Tao Z; Chen S Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Dec; 35(12):1149-1152. PubMed ID: 34886636 [No Abstract] [Full Text] [Related]
69. A Multicenter Study of Prevalence and Risk Factors for Allergic Rhinitis in Primary School Children in 5 Cities of Hubei Province, China. Tong X; Tong H; Gao L; Deng Y; Xiang R; Cen R; Zhao Y; Wang P; Li G; Shen J; Xu B; He B; Kong Y; Tao Z; Xu Y; Int Arch Allergy Immunol; 2022; 183(1):34-44. PubMed ID: 34515115 [TBL] [Abstract][Full Text] [Related]
70. Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood health. Rose K; Kopp MV Pediatr Allergy Immunol; 2015 Dec; 26(8):695-701. PubMed ID: 26495999 [TBL] [Abstract][Full Text] [Related]
71. Consensus on the methodology for experimental studies in allergic rhinitis. Kar M; Bayar Muluk N; Bafaqeeh SA; Cingi C Int J Pediatr Otorhinolaryngol; 2019 Jun; 121():68-71. PubMed ID: 30877977 [TBL] [Abstract][Full Text] [Related]
72. Exposure to environmental factors and relationship to allergic rhinitis and/or asthma. Azalim S; Camargos P; Alves AL; Senna MI; Sakurai E; Schwabe Keller W Ann Agric Environ Med; 2014; 21(1):59-63. PubMed ID: 24738498 [TBL] [Abstract][Full Text] [Related]
73. Allergy immunotherapy for allergic rhinitis effectively prevents asthma: Results from a large retrospective cohort study. Schmitt J; Schwarz K; Stadler E; Wüstenberg EG J Allergy Clin Immunol; 2015 Dec; 136(6):1511-1516. PubMed ID: 26371838 [TBL] [Abstract][Full Text] [Related]
74. Investigational new drugs for allergic rhinitis. Ricketti PA; Alandijani S; Lin CH; Casale TB Expert Opin Investig Drugs; 2017 Mar; 26(3):279-292. PubMed ID: 28141955 [TBL] [Abstract][Full Text] [Related]
75. Current issues on sublingual allergen-specific immunotherapy in children with asthma and allergic rhinitis. Živković Z; Djurić-Filipović I; Živanović S Srp Arh Celok Lek; 2016; 144(5-6):345-50. PubMed ID: 29648760 [TBL] [Abstract][Full Text] [Related]
76. Safety and efficacy of rush allergen-specific immunotherapy in Chinese allergic rhinitis patients. Qiu Q; Xu M; Lu C; Chen J; Chen S; Kong W; Han H Int J Immunopathol Pharmacol; 2016 Dec; 29(4):720-725. PubMed ID: 27510816 [TBL] [Abstract][Full Text] [Related]
77. [Allergic rhinitis in pediatrics: recommendations for diagnosis and treatment]. Agüero CA; Sarraquigne MP; Parisi CAS; Mariño AI; López K; Menéndez Porfirio B; Sasia L; Lozano A; Bovina Martijena MDP; Gervasoni ME; Bózzola M; Colella M; Saranz R; Orellana J; Máspero JF; Seisdedos V; Behrends I; Blanco A; Dayán P; Matta Ruffolo M; Aráoz I; Casaniti C; García J; Skrie V; García M; Suárez García JM; Orellano F; Luconi N; Bandin G Arch Argent Pediatr; 2023 Apr; 121(2):e202202894. PubMed ID: 36924507 [TBL] [Abstract][Full Text] [Related]
78. Sublingual immunotherapy for allergic rhinitis. Wilson DR; Torres LI; Durham SR Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442 [TBL] [Abstract][Full Text] [Related]
79. [Clinical analysis of allergic rhinitis in children between 1 and 3 years of age]. Dai WL; Zhang J; Pan YS; Chen M; Zhang YM Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Nov; 46(11):921-7. PubMed ID: 22335979 [TBL] [Abstract][Full Text] [Related]
80. [Definition and clinic of the allergic rhinitis]. Spielhaupter M Med Monatsschr Pharm; 2016 Mar; 39(3):97-9. PubMed ID: 27120868 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]